Cryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage determinations for cryoablation, radiofrequency ablation, and laser ablation procedures targeting the posterior nasal nerve for treatment of chronic rhinitis for Blue Cross Blue Shield - Rhode Island members.
No material clinical or coverage changes in this revision.
Coverage Determinations
Overall coverage determination
Policy statements
[[chunk 5]]
[[chunk 6]]
CPT codes 31242 and 31243 are explicitly listed as not covered for Medicare Advantage Plans and as not medically necessary for Commercial Products when billed with the specified ICD-10-CM diagnosis codes.
This medical policy is provided for informational purposes and is not a guarantee of payment. Coverage, benefits, and eligibility are governed by the member's subscriber agreement or member certificate and/or the employer agreement, and those documents supersede this medical policy.
For Commercial Products, cryoablation, radiofrequency ablation, and laser ablation for chronic rhinitis (allergic or nonallergic) are considered not medically necessary because the evidence is insufficient to determine effects on health outcomes. CPT codes 31242 and 31243 are identified in the policy as the procedure codes associated with these services.
Services determined to be not medically necessary or that are non‑covered benefits may not be paid by the plan and could result in financial responsibility for the member unless the member has been informed and has provided written agreement to pay in advance.
Coding
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| J31.0 | Chronic rhinitis |
| K190356 | Clarifix 510(k) Premarket Notification |
| K192471 | RhinAer (RHIN1 Stylus) 510(k) Premarket Notification |
| K212666 | Neuromark System 510(k) Premarket Notification |
Provider Actions and Billing Guidance
Prior authorization not required
Prior authorization is not applicable for posterior nasal nerve ablation procedures under this policy.
Verify member benefits and eligibility
Verify member benefits and eligibility prior to scheduling procedures; coverage and payment are governed by the member's subscriber agreement, member certificate, or employer agreement which supersede this policy.
Document prior medical therapy (medical management required)
Confirm that patients have had adequate medical management (intranasal steroids, anticholinergics, nasal decongestants, or antihistamines) and document refractory chronic rhinitis as persistent symptoms despite adequate medical therapy before considering ablation.
- Initial medical therapy may include steroids, anticholinergics, nasal decongestants, and antihistamines.
- Refractory chronic rhinitis is defined as persistent symptoms despite adequate medical therapy.
Document clinical rationale and prior therapies
Ensure clinical documentation clearly supports any proposed intervention and includes prior therapies tried and symptom persistence; follow payer guidance for benefit verification and coding.
- Document trials of adequate medical therapy and persistent symptoms.
- Record the ICD-10-CM diagnosis code(s) used to justify the procedure.
Coding: Do not use 31242/31243; use unlisted codes if needed
When filing claims, do not use CPT codes 31242 or 31243 (these codes are listed as not covered/not medically necessary when filed with the listed ICD-10-CM codes); use unlisted procedure codes 30999 (nose) or 31299 (accessory sinuses) when no applicable HCPCS/CPT code is assigned.
Contact provider call center for benefits verification
For member-specific benefits and eligibility questions, contact the provider call center; subscriber agreement or member certificate determines coverage.
- Call the provider call center for verification of benefits and eligibility.
High risk of coverage denial for these procedures
Claims for cryoablation, radiofrequency ablation, and laser ablation for chronic rhinitis are not covered for Medicare Advantage plans and are considered not medically necessary for Commercial products; filing with CPT codes 31242 and 31243 may result in denial.
Risk of member financial liability for non-covered or not medically necessary services
If a service is determined to be not medically necessary or a non-covered benefit, the provider may not be permitted to bill the member unless the member has provided written agreement in advance to pay; verify and obtain written consent if applicable.
- Providers must obtain written member agreement in advance if member will be billed for non-covered services.
Background
Chronic rhinitis, which includes both allergic and nonallergic forms, is a common condition that can substantially impair quality of life through persistent nasal congestion and rhinorrhea. First‑line treatment is medical therapy such as intranasal steroids, topical anticholinergics, oral decongestants, and antihistamines; despite these measures, an estimated portion of patients remain symptomatic. When medical therapy fails to control symptoms, interventions targeting the posterior nasal nerve (including cryoablation, radiofrequency, laser, or surgical neurectomy) have been investigated to reduce parasympathetic‑mediated glandular secretion and nasal blood flow with the goal of improving rhinorrhea and congestion.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.